期刊文献+

一种“二阶段补钙模型”在RCA-CVVH中的临床应用 被引量:2

Clinical application of the two-stage calcium supplement model in continuous venous-venous hemofiltration under regional citrate anticoagulation(RCA-CVVH)
下载PDF
导出
摘要 目的基于"二阶段补钙模型"建立补钙方程并加以临床实践,以更加简便、有效的推广枸橼酸抗凝技术。方法选取上海交通大学医学院附属第九人民医院行肾脏替代治疗的患者共50人、共进行有效局部枸橼酸抗凝下连续静脉静脉血液滤过(continuous venous-venous hemofiltration under regional citrate anticoagulation,RCA-CVVH)计156例次,其中连续静脉静脉血液滤过(continuous venous-venous hemofiltration,CVVH)采用前稀释模式、低碱无钙置换液,置换液速度4L/h,治疗时间6~8h。循环管路动脉端输注血液保存液-a(anticoagulant citrate dextrose solution-a,ACDa),枸橼酸以4~4.5mmol/L血浆流量速度输入;静脉端补充5%氯化钙,补钙速率利用"二阶段补钙模型"计算得出。在CVVH治疗过程中观察滤器凝血程度,并且每2~3h用i Stat生化仪监测动脉端、滤器前的游离钙水平,留取动脉端1ml血液检测总钙水平,并计算得出动脉端总钙/离子钙水平。结果在156例CVVH中,RCA抗凝有效占总次数的96.79%(151/156),抗凝效果理想;90.4%的管路滤器前离子钙浓度在0.2~0.4mmol/L,均在目标范围内;90.5%的管路动脉端离子钙监测结果均在1.0~1.2mmol/L;97.14%的体内总钙与离子钙比值结果<2.5,无枸橼酸蓄积倾向;熟练应用"二阶段补钙方程"可明显减少离子钙监测频率,减少人力、物力、财力。结论二阶段补钙模型有效性、安全、简便,具有良好的临床实用性。 Objective: To promote the local citrate anticoagulation simplely and effectively,we established equation and practiced in clinical based on the "two-stage calcium supplement model". Methods: There were 156 cases with effective continuous venous-venous hemofiltration under regional citrate anticoagulation (RCA-CVVH) in a total 50 patients selected. The continuous venous-venous hemofiltration (CVVH) mode was pre-dilution with the low-base calcium-free replacement solution which speed was 4L/h.The treatments lasted 6-8 hours. The anticoagulant citrate dextrose solution-a(ACD-a) was infused at arterial end, and the citrate was fed with 4 ~ 4.5 mmol / L plasma flow. The venous end was supplemented with 5% calcium chloride, and the calcium rate was calculated with the "two-stage calcium supplement model" . The degree of coagulation was observed during CVVH treatment. The mean calcium level was measured by the iState biochemical analyzer every 2-3 hours. The total calcium level was measured at the arterial end and the total calcium / ion calcium level was calculated. Results: In 156 cases of CVVH, the efficiency of anticoagulation with RCA accounted for 96.79%(151/156),and the anticoagulation effect was ideal.90.4% of the concentration of ionized calcium in ore-filter were 0.2-0.4mmol / L,which were within the target range.90.5% of the concentration of ionized calcium in arterial port were 1.0-1.2mmol / L. 97.14% of the ratio of total calcium and ionized calcium were less than 2.5 in vivo with no citrate accumulation tendency. Skilled application of "two-stage calcium supplement equation" can significantly reduce the frequency of ion-calcium monitoring,and reduce the manpower, material and financial resources. Conclusions: The two-stage calcium supplement model is effective, safe and simple,and it has good clinical Practicality.
作者 庄峰 俞雯艳 马帅 卢建新 陆伟 丁峰 ZHUANG Feng;YU Wen-yan;MA Shuai;LU Jian-xin;LU Wei;DING Feng(Division of Nephrology & Critical Care Nephrology Unit,Shanghai Ninth People 's Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200011,China)
出处 《中国血液净化》 2018年第7期461-465,共5页 Chinese Journal of Blood Purification
基金 国家自然科学基金(编号:81270850 81470990) 上海市科委科技支撑项目(编号:17441904200) 上海市浦东新区卫计委联合攻关项目(编号:PW2015D-4) 上海交通大学医工交叉重点项目(YG2014ZD06) 上海交通大学医学院附属第九人民医院临床研究助推计划(编号:JYLJ007)
关键词 枸橼酸抗凝 二阶段补钙 肾脏替代治疗 Local citrate aaaticoagulation Two-stage calcium supplementation Renal replacement daerapy
  • 相关文献

参考文献1

二级参考文献13

  • 1Kutsogiannis DJ,Mayers I,Chin WD,et al.Regional citrate anticoagulation in continuous venovenous hemodiafiltration.Am J Kidney Dis,2002,35:802-811.
  • 2Tolwani AJ,Prendergast MB,Speer RR,et al.A practical citrate Anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance.Clin J Am Soc Nephrol,2006,1:79-87.
  • 3Bunker JP,Bendixen HH,Murphy AJ.Hemodynamic effects of intravenously administered sodium citrate.N Engl J Med,1962,266:372-377.
  • 4Kutsogiannis DJ,Gibney RT,Stollery D,et al.Regional citrate versus systemic heparin anticongulation for continuous renal replacement in critically ill patients.Kidney Int,2005,67:2361-2367.
  • 5Hofbauer R,Moser D,Frass M,et al.Effect of anticoagulation on blood membrane interactions during hemodialysis.Kidney Int,1999,56:1578-1583.
  • 6Bagshaw SM,Laupland KB,Boiteau PJ,et al.Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.Crit Care,2005,20:155-161.
  • 7Dhondt A,Vanholder R,Tielemans C,et al.Effect of regional citrate anti-coagulation on leucopenia,complement activation,and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membranes.Nephron,2000,85:334-342.
  • 8Bohder J,Sehollmeyer P,Dressel B,et al.Reduction of granulocyte activation during hemodialysis with regional citrate antieoagulation:dissociation of complement activation and neutropenia from neutrophil degranulation.J Am Soc Nephrol,1996,7:234-241.
  • 9Gritters M,Muriel P,Grooteman C.Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis.Nephrol Dial Transplant,2006,21:153-159.
  • 10Oudemans-van Straaten HM,Bosman RJ,Koopmans MR,et al.Citrate anticoagulation for continuous venovenous hemofiltration.Crit Care Med,2009,37:545-552.

共引文献13

同被引文献20

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部